Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 23:40:32 UTC
Update Date2021-09-26 23:18:05 UTC
HMDB IDHMDB0260138
Secondary Accession NumbersNone
Metabolite Identification
Common Name(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid
Description3-{[hydroxy({4-oxo-5-[2-(piperidin-4-yl)ethyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl})methylidene]amino}-2-(4-methylbenzenesulfonamido)propanoic acid belongs to the class of organic compounds known as tyrosine and derivatives. Tyrosine and derivatives are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Based on a literature review very few articles have been published on 3-{[hydroxy({4-oxo-5-[2-(piperidin-4-yl)ethyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl})methylidene]amino}-2-(4-methylbenzenesulfonamido)propanoic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). (2s)-2-[(4-methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6h-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
3-{[hydroxy({4-oxo-5-[2-(piperidin-4-yl)ethyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl})methylidene]amino}-2-(4-methylbenzenesulfonamido)propanoateGenerator
3-{[hydroxy({4-oxo-5-[2-(piperidin-4-yl)ethyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl})methylidene]amino}-2-(4-methylbenzenesulphonamido)propanoateGenerator
3-{[hydroxy({4-oxo-5-[2-(piperidin-4-yl)ethyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl})methylidene]amino}-2-(4-methylbenzenesulphonamido)propanoic acidGenerator
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoateGenerator
(2S)-2-[(4-Methylphenyl)sulphonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoateGenerator
(2S)-2-[(4-Methylphenyl)sulphonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acidGenerator
Chemical FormulaC25H34N6O6S
Average Molecular Weight546.64
Monoisotopic Molecular Weight546.226054013
IUPAC Name2-(4-methylbenzenesulfonamido)-3-({4-oxo-5-[2-(piperidin-4-yl)ethyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}formamido)propanoic acid
Traditional Name2-(4-methylbenzenesulfonamido)-3-({4-oxo-5-[2-(piperidin-4-yl)ethyl]-6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}formamido)propanoic acid
CAS Registry NumberNot Available
SMILES
CC1=CC=C(C=C1)S(=O)(=O)NC(CNC(=O)C1=NN2CCCN(CCC3CCNCC3)C(=O)C2=C1)C(O)=O
InChI Identifier
InChI=1S/C25H34N6O6S/c1-17-3-5-19(6-4-17)38(36,37)29-21(25(34)35)16-27-23(32)20-15-22-24(33)30(12-2-13-31(22)28-20)14-9-18-7-10-26-11-8-18/h3-6,15,18,21,26,29H,2,7-14,16H2,1H3,(H,27,32)(H,34,35)
InChI KeyYLFFZEQHDMFOEC-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as tyrosine and derivatives. Tyrosine and derivatives are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentTyrosine and derivatives
Alternative Parents
Substituents
  • Tyrosine or derivatives
  • Phenylalanine or derivatives
  • Alpha-amino acid ester
  • 3-phenylpropanoic-acid
  • Phenol ester
  • Amphetamine or derivatives
  • Alpha-amino acid
  • Nitrobenzene
  • Phenoxy compound
  • Nitroaromatic compound
  • 1-hydroxy-2-unsubstituted benzenoid
  • Aralkylamine
  • Phenol
  • Fatty acid ester
  • Fatty acyl
  • Benzenoid
  • Dicarboxylic acid or derivatives
  • Monocyclic benzene moiety
  • Amino acid
  • Organic nitro compound
  • C-nitro compound
  • Carboxylic acid ester
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Allyl-type 1,3-dipolar organic compound
  • Organic oxoazanium
  • Carboxylic acid
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organic zwitterion
  • Primary amine
  • Organooxygen compound
  • Organonitrogen compound
  • Primary aliphatic amine
  • Carbonyl group
  • Amine
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP0.22ALOGPS
logP-2.2ChemAxon
logS-3.8ALOGPS
pKa (Strongest Acidic)2.52ChemAxon
pKa (Strongest Basic)10.07ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area162.73 ŲChemAxon
Rotatable Bond Count9ChemAxon
Refractivity151.88 m³·mol⁻¹ChemAxon
Polarizability57.7 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
AllCCS[M+H]+221.28132859911
AllCCS[M+H-H2O]+220.0132859911
AllCCS[M+Na]+222.74632859911
AllCCS[M+NH4]+222.42432859911
AllCCS[M-H]-207.54232859911
AllCCS[M+Na-2H]-209.32632859911
AllCCS[M+HCOO]-211.42132859911
DeepCCS[M+H]+220.91730932474
DeepCCS[M-H]-218.52230932474
DeepCCS[M-2H]-251.40530932474
DeepCCS[M+Na]+226.92830932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acidCC1=CC=C(C=C1)S(=O)(=O)NC(CNC(=O)C1=NN2CCCN(CCC3CCNCC3)C(=O)C2=C1)C(O)=O6470.6Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acidCC1=CC=C(C=C1)S(=O)(=O)NC(CNC(=O)C1=NN2CCCN(CCC3CCNCC3)C(=O)C2=C1)C(O)=O3733.0Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acidCC1=CC=C(C=C1)S(=O)(=O)NC(CNC(=O)C1=NN2CCCN(CCC3CCNCC3)C(=O)C2=C1)C(O)=O4937.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C=C14574.5Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C=C14411.1Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C=C16710.4Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #2CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O[Si](C)(C)C)C=C14517.6Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #2CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O[Si](C)(C)C)C=C14303.1Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #2CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O[Si](C)(C)C)C=C16498.2Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #3CC1=CC=C(S(=O)(=O)NC(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C)C=C14698.3Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #3CC1=CC=C(S(=O)(=O)NC(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C)C=C14359.1Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #3CC1=CC=C(S(=O)(=O)NC(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C)C=C16757.6Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #4CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O)[Si](C)(C)C)C=C14592.1Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #4CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O)[Si](C)(C)C)C=C14524.5Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #4CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O)[Si](C)(C)C)C=C16592.0Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #5CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)C(=O)O)[Si](C)(C)C)C=C14783.6Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #5CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)C(=O)O)[Si](C)(C)C)C=C14551.2Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #5CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)C(=O)O)[Si](C)(C)C)C=C16846.3Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #6CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O)C=C14750.9Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #6CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O)C=C14494.2Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TMS,isomer #6CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O)C=C16661.4Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C=C14462.1Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C=C14575.7Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C=C16218.3Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TMS,isomer #2CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C=C14656.5Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TMS,isomer #2CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C=C14613.0Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TMS,isomer #2CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C=C16509.0Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TMS,isomer #3CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O[Si](C)(C)C)C=C14609.1Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TMS,isomer #3CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O[Si](C)(C)C)C=C14509.2Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TMS,isomer #3CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O[Si](C)(C)C)C=C16253.0Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TMS,isomer #4CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O)[Si](C)(C)C)C=C14704.5Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TMS,isomer #4CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O)[Si](C)(C)C)C=C14722.9Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TMS,isomer #4CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O)[Si](C)(C)C)C=C16393.1Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,4TMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C=C14594.7Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,4TMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C=C14783.8Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,4TMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C)C=C16029.0Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15025.4Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C14891.2Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C16629.0Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #2CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)C=C14991.6Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #2CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)C=C14764.7Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #2CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)C=C16388.6Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #3CC1=CC=C(S(=O)(=O)NC(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C(C)(C)C)C=C15187.6Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #3CC1=CC=C(S(=O)(=O)NC(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C(C)(C)C)C=C14805.9Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #3CC1=CC=C(S(=O)(=O)NC(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C(C)(C)C)C=C16730.2Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #4CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C)C=C15086.2Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #4CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C)C=C14960.2Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #4CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C)C=C16506.5Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #5CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)C(=O)O)[Si](C)(C)C(C)(C)C)C=C15243.5Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #5CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)C(=O)O)[Si](C)(C)C(C)(C)C)C=C14976.2Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #5CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)C(=O)O)[Si](C)(C)C(C)(C)C)C=C16845.0Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #6CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O)C=C15244.8Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #6CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O)C=C14908.6Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #6CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O)C=C16631.4Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15099.3Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15260.9Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #1CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCNCC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C16104.5Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #2CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15290.6Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #2CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15286.7Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #2CC1=CC=C(S(=O)(=O)N(C(CNC(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C16451.8Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #3CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)C=C15250.2Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #3CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)C=C15166.4Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #3CC1=CC=C(S(=O)(=O)NC(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)C=C16205.6Standard polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #4CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C)C=C15348.1Semi standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #4CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C)C=C15352.2Standard non polar33892256
(2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #4CC1=CC=C(S(=O)(=O)N(C(CN(C(=O)C2=NN3CCCN(CCC4CCN([Si](C)(C)C(C)(C)C)CC4)C(=O)C3=C2)[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C)C=C16345.1Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid GC-MS (TMS_1_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid GC-MS (TMS_1_4) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid GC-MS (TBDMS_1_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2S)-2-[(4-Methylphenyl)sulfonylamino]-3-[[4-oxo-5-(2-piperidin-4-ylethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepine-2-carbonyl]amino]propanoic acid GC-MS (TBDMS_1_4) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID13207100
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound22991813
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]